-
Abstract Number: 1614
Use of a Best Practice Alert to Encourage Transition Planning and Readiness
-
Abstract Number: 1615
Assessing Preparation for Care Transition Among Adolescents with Rheumatologic Disease: A Quality Assessment with Patient Survey
-
Abstract Number: 1616
Systematic Review of Effectiveness Outcomes Reported in Rheumatology Transition Literature
-
Abstract Number: 1617
New Juvenile Idiopathic Arthritis Quality Measure Set for the Pediatric Rheumatology Care and Outcomes Improvement Network
-
Abstract Number: 1618
Frequency and Cost of Repeat HLA-B27 Testing Within the National Capital Consortium over a Calendar Year
-
Abstract Number: 1619
Immunoglobulin G Subclass Ordering Patterns for IgG4-Related Disease at an Academic Medical Center
-
Abstract Number: 1620
Hepatitis B Screening Practices When Prescribing Tocilizumab or Tofacitinib in Real World Practice
-
Abstract Number: 1621
Cervical Cancer Screening Among Women with Systemic Lupus Erythematosus or Prescribed Tumor Necrosis Alpha-inhibitors Who Receive Outpatient Rheumatology Care
-
Abstract Number: 1622
Determining the Zoster Vaccination Rate Among Veterans on Chronic Immunosuppressive Therapy at the Southeast Louisiana Veterans Healthcare System – a Quality Indicator
-
Abstract Number: 1623
Improving Pneumococcal Vaccination Rates Among Immunosuppressed Adults in an Academic Rheumatology Clinic Utilizing a Nurse Driven Protocol
-
Abstract Number: 1624
Improving Pneumococcal Vaccination in Veterans with Rheumatic Diseases
-
Abstract Number: 1625
Pneumocystis Jiroveci Pneumonia in Immunocompromised Patients with Rheumatologic Disease in a Single, Tertiary Medical Center
-
Abstract Number: 1626
Long-Term Follow-Up of Renal Transplantation Due to Lupus Nephritis. Single Universitary Center Experience
-
Abstract Number: 1627
Phase I Trial of High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients with Mild COVID-19: A Study in the Effects of Shifting Public Opinion on Patient Enrollment
-
Abstract Number: 1628
Management of Gout After Pegloticase; Observations of US Clinical Practice from Trio Health and the American Rheumatology Network (ARN)
- « Previous Page
- 1
- …
- 108
- 109
- 110
- 111
- 112
- …
- 139
- Next Page »